Search

A new initiative aims to develop computer and cell-based alternatives to animal toxicity testing, with the aim of replacing the use of one million animals each year in Europe.

Roland Siegwart plans to build on ETH Zurich's successful start-up ecosystem, improving support and fostering interdisciplinary cooperation.

A week before Science|Business brings together experts from Europe to discuss personalised medicine here, we look at what’s happening in the US.

A contest between Australia and South Africa over the world’s biggest radio telescope highlights the economic impact of ‘Big Science’.

France’s software sector has resisted the economic crisis and is innovating and creating jobs, with SMEs driving the industry, says a new report.

ACES winner Nikolaos Vlasopoulos is hoping to turn the cement industry upside down with a low-carbon, environmentally friendly variant of the old standby.

There is still uncertainty among investors about the commercial promise of the emerging field of personalised medicine.

EU rules on R&D funding are too onerous, MEP Jorgo Chatzimarkakis tells Science|Business’s Anna Jenkinson.